Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Anabolic and molecular interventions on muscle : Meaningful anti-aging strategy?]

Literature DB >> 28808776

[Anabolic and molecular interventions on muscle : Meaningful anti-aging strategy?]

Thomas Münzer¹.

Abstract

Mesh：

Substances：

Year: 2017 PMID： 28808776 DOI： 10.1007/s00391-017-1299-y

Source DB: PubMed Journal: Z Gerontol Geriatr ISSN： 0948-6704 Impact factor: 1.281

× No keyword cloud information.

33 in total

Review 1. Systematic review: the safety and efficacy of growth hormone in the healthy elderly.

Authors: Hau Liu; Dena M Bravata; Ingram Olkin; Smita Nayak; Brian Roberts; Alan M Garber; Andrew R Hoffman
Journal: Ann Intern Med Date: 2007-01-16 Impact factor: 25.391

Review 2. Myostatin and sarcopenia: opportunities and challenges - a mini-review.

Authors: Thomas A White; Nathan K LeBrasseur
Journal: Gerontology Date: 2014-01-17 Impact factor: 5.140

Review 3. Life-extension: a biomedical goal? Scientific prospects, ethical concerns.

Authors: Gaia Barazzetti; Massimo Reichlin
Journal: Swiss Med Wkly Date: 2011-04-13 Impact factor: 2.193

4. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.

Authors: Clemens Becker; Stephen R Lord; Stephanie A Studenski; Stuart J Warden; Roger A Fielding; Christopher P Recknor; Marc C Hochberg; Serge L Ferrari; Hubert Blain; Ellen F Binder; Yves Rolland; Serge Poiraudeau; Charles T Benson; Stephen L Myers; Leijun Hu; Qasim I Ahmad; Kelli R Pacuch; Elisa V Gomez; Olivier Benichou
Journal: Lancet Diabetes Endocrinol Date: 2015-10-27 Impact factor: 32.069

5. DHEA in elderly women and DHEA or testosterone in elderly men.

Authors: K Sreekumaran Nair; Robert A Rizza; Peter O'Brien; Ketan Dhatariya; Kevin R Short; Ajay Nehra; Janet L Vittone; George G Klee; Ananda Basu; Rita Basu; Claudio Cobelli; Gianna Toffolo; Chiara Dalla Man; Donald J Tindall; L Joseph Melton; Glenn E Smith; Sundeep Khosla; Michael D Jensen
Journal: N Engl J Med Date: 2006-10-19 Impact factor: 91.245

6. A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty.

Authors: L Woodhouse; R Gandhi; S J Warden; S Poiraudeau; S L Myers; C T Benson; L Hu; Q I Ahmad; P Linnemeier; E V Gomez; O Benichou
Journal: J Frailty Aging Date: 2016

[Anabolic and molecular interventions on muscle : Meaningful anti-aging strategy?]

Review 1. Systematic review: the safety and efficacy of growth hormone in the healthy elderly.

Review 2. Myostatin and sarcopenia: opportunities and challenges - a mini-review.

Review 3. Life-extension: a biomedical goal? Scientific prospects, ethical concerns.

4. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.

5. DHEA in elderly women and DHEA or testosterone in elderly men.

6. A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty.

7. Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials.

Review 8. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Review 9. Frailty and its potential relevance to cardiovascular care.

10. Elevated expression of activins promotes muscle wasting and cachexia.

Review 1. [Doping with illegal and legal substances in old age].